Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
J Appl Physiol (1985) ; 129(5): 1173-1182, 2020 11 01.
Article de Anglais | MEDLINE | ID: mdl-32940562

RÉSUMÉ

We aimed to examine biomechanical and neuroautonomic adaptation to blood volume displacement induced by tilt test in patients with previous inferoapical/inferolateral (IA-IL) or basal/apical septal (BS-AS) myocardial infarction (MI). Twenty-four patients with heart failure (HF) and previous IA-IL MI and 30 patients with HF and previous BS-AS MI were enrolled. All patients underwent head-up tilt test, radionuclide ventricular function monitoring (VEST), sympathovagal balance evaluation, and chronotropic 25-dose isoproterenol infusion test (CD25). Physiopathological reactions to stress-tests were assessed in both groups. Follow-up lasted 36 mo. IA-IL patients showed lower stroke volume (SV), cardiac output (CO), and left ventricle ejection fraction (LVEF) compared with BS-AS. End-diastolic volume decreased in IA-IL group (F = 3.1, P = 0.043) more than in BS-AS group during tilt test. The time trend of end-systolic volume, SV, CO, LVEF, and peak filling rate were similar in the two groups. Norepinephrine (IA-IL supine→tilting 499.5 (SD:28.8)→719.3 (SD:41.5) pg/mL vs. BS-AS supine→tilting 533.9 (SD:33.3)→768.8 (SD:47.9) pg/mL; P < 0.001) and epinephrine plasma concentrations (IA-IL supine→ tilting 125.7 (SD:9.8)→193.7 (SD:9.6) pg/mL vs. BS-AS supine→ tilting 118.8 (SD:8.9)→191.7 (SD:10.2) pg/mL; P < 0.001) increased in both groups. Low-to-high frequencies ratio significantly increased in IA-IL and decreased in BS-AS patients. CD25 was similar in IA-IL and BS-AS patients (IA-IL = 4.6 (SD:0.94), BS-AS = 5.0 (SD:1.06) µg; P = 0.79). CD25 predicted all-cause mortality (hazard ratio 1.48, 95% confidence interval 1.32-1.67; P < 0.0001) after adjusting for age/heart rate. In conclusion, patients with ischemic HF show abnormal biomechanical adaptation to volume displacement and compensatory sympathetic overdrive. The association of reduced ß-adrenergic sensitivity and sympathetic denervation in such patients warrants for careful therapeutic choices.NEW & NOTEWORTHY The adaptation to volume displacement induced by tilt test was assessed in patients with heart failure and previous inferoapical/inferolateral or basal/apical septal myocardial infarction. The responsiveness of cardiac muscle to sympathetic nervous system stimulation predicts the mortality in patients with ischemic heart failure and may represent a useful tool for clinicians in the general assessment of this kind of patients.


Sujet(s)
Adaptation physiologique , Cardiomyopathie dilatée , Débit systolique , Volume sanguin , Rythme cardiaque , Humains , Test d'inclinaison , Fonction ventriculaire gauche
3.
J Invasive Cardiol ; 31(3): 52-56, 2019 03.
Article de Anglais | MEDLINE | ID: mdl-30819975

RÉSUMÉ

OBJECTIVES: One of the procedural concerns during percutaneous treatment of patients with concomitant coronary artery disease (CAD) and aortic valve stenosis (AS) is the risk of hemodynamic instability. In the present study, we assessed the safety and effectiveness of elective hemodynamic support with the Impella 2.5 system (Abiomed, Inc) in patients undergoing combined high-risk percutaneous coronary intervention (PCI) and balloon aortic valvuloplasty (BAV), as a bridge to transcatheter aortic valve replacement. METHODS: Ten patients suffering from acute coronary syndrome (ACS) and severe AS were included. In all patients, we first performed PCI with the hemodynamic support of the Impella 2.5 system, and then BAV. RESULTS: The Impella catheter was successfully positioned in the left ventricle in all instances. All cases were successful, without any intraprocedural complications. All patients were discharged without any major clinical events. CONCLUSIONS: These preliminary results suggest that elective use of the Impella 2.5 system is safe and effective when performing PCI and BAV in high-risk ACS patients suffering from concomitant severe CAD and AS.


Sujet(s)
Sténose aortique/épidémiologie , Sténose aortique/chirurgie , Maladie des artères coronaires/épidémiologie , Maladie des artères coronaires/chirurgie , Intervention coronarienne percutanée/méthodes , Remplacement valvulaire aortique par cathéter/méthodes , Sujet âgé , Sujet âgé de 80 ans ou plus , Sténose aortique/imagerie diagnostique , Études de cohortes , Comorbidité , Maladie des artères coronaires/imagerie diagnostique , Interventions chirurgicales non urgentes , Femelle , Études de suivi , Dispositifs d'assistance circulatoire , Humains , Complications peropératoires/prévention et contrôle , Mâle , Études prospectives , Indice de gravité de la maladie , Résultat thérapeutique
6.
J Cardiovasc Med (Hagerstown) ; 16 Suppl 1: S15-7, 2015 Jan.
Article de Anglais | MEDLINE | ID: mdl-25643062

RÉSUMÉ

Ventricular septal defect (VSD) is a life-threatening complication of acute myocardial infarction (MI), resulting in high mortality rate even in the case of a timely approach by surgical repair. Transcatheter closure is nowadays a reliable alternative to surgery, although currently deemed challenging or unsuitable in large and complex VSD. This article reports on a successful transcatheter approach in a critically ill patient with subacute right coronary-related, complex postinfarction VSD. In this patient, two sequentially deployed Amplatzer Septal Occluder devices stabilized the clinical conditions and hemodynamic parameters.


Sujet(s)
Cathétérisme cardiaque/instrumentation , Procédures de chirurgie cardiaque/instrumentation , Échocardiographie , Communications interventriculaires/étiologie , Communications interventriculaires/chirurgie , Infarctus du myocarde/complications , Cathétérisme cardiaque/méthodes , Procédures de chirurgie cardiaque/méthodes , Femelle , Communications interventriculaires/imagerie diagnostique , Humains , Adulte d'âge moyen , Infarctus du myocarde/imagerie diagnostique , Résultat thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE